Bioviva has a total of 11 patents globally, out of which 1 have been granted. Of these 11 patents, more than 54% patents are active. The United States of America is where Bioviva has filed the maximum number of patents, followed by Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Bioviva.
Bioviva was founded in 2015. The company makes treatments to help damaged cells work better and fix problems caused by faulty genes. This could help people with diseases like Alzheimer’s and cystic fibrosis.
Do read about some of the most popular patents of Bioviva which have been covered by us in this article and also you can find Bioviva patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Bioviva patent portfolio.
How many patents does Bioviva have?
Bioviva has a total of 11 patents globally. These patents belong to 4 unique patent families. Out of 11 patents, 6 patents are active.
How Many Patents did Bioviva File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Bioviva Applications Filed | Bioviva Patents Granted |
| 2022 | 7 | 1 |
| 2019 | 1 | – |
| 2016 | 2 | – |
| 2014 | 1 | – |
How many Bioviva patents are Alive/Dead?
Worldwide Patents
How Many Patents did Bioviva File in Different Countries?
Countries in which Bioviva Filed Patents
| Country | Patent |
| United States Of America | 8 |
| Europe | 1 |
Where are Research Centers of Bioviva Patents Located?
The Research Centers of Bioviva Patents is the United States of America.
What Percentage of Bioviva US Patent Applications Were Granted?
Bioviva (Excluding its subsidiaries) has filed 6 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 25%.
Below are the key stats of Bioviva patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Bioviva?
| Law Firm | Total Applications | Success Rate |
| Workman Nydegger | 6 | 25% |
List of Bioviva patents
| Bioviva Patents | Title |
| US11266721B1 | Methods Of Treating Or Preventing Age Related Disorders |
| US20220401583A1 | Treatment Of Age-Related Cognitive Decline Using Genetically Modified Viral Vectors |
| US20220251603A1 | Systems And Methods For Gene Therapy Via Administration Of Genetically Modified Viral Vectors |
| US20220177921A1 | Gene Therapy Using Genetically Modified Viral Vectors |
| US20220143218A1 | Methods Of Treating Or Preventing Age-Related Disorders |
| EP4288554A1 | Systems And Methods For Gene Therapy Via Administration Of Genetically Modified Viral Vectors |
| US20200061210A1 | Novel Method For Gene Therapy Using Intranasal Administration Of Genetically Modified Viral Vectors |
| US20160193251A1 | Method For Treating Als Via The Increased Production Of Factor H |
| US20140234275A1 | Method For Treating Als Via The Increased Production Of Factor H |
| WO2022266347A1 | Treatment Of Age-Related Cognitive Decline Using Genetically Modified Viral Vectors |
| WO2022170056A1 | Systems And Methods For Gene Therapy Via Administration Of Genetically Modified Viral Vectors |
What are Bioviva key innovation segments?
What Technologies are Covered by Bioviva?
The chart below distributes patents filed by Bioviva in different countries on the basis of the technology protected in patents. It also represents the markets where Bioviva thinks it’s important to protect particular technology inventions.
R&D Focus: How has Bioviva search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Bioviva?